Healthcare & Life Sciences
Initial Therapeutics
series-a
series-a
Stage
1
Investors
About
Initial Therapeutics is a biotechnology company launched with financing from Apple Tree Partners to develop a new class of drugs designed to prevent the formation of difficult-to-drug protein targets.
Explore Initial Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.